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A reliable new procedure is described for the reconstitution of Sendai viral envelopes suitable for gene transfer. Both
fusion and hemagglutinin-neuraminidase glycoproteins were extracted from purified Sendai virus and reconstituted together
with DNA in the presence of cholesterol:sphingomyelin:phosphatidylcholine:phosphatidylethanolamine (Chol:SM:PC:PE) in a
molar ratio of 3.5:3.5:2:1. Before reconstitution, the DNA to be transferred was condensed by pretreatment with polylysine.
Exogenous lipid addition and the DNA-condensation step were essential for maximal size as well as for fusogenic activity of
the resulting virosomes, the analysis of which revealed (1) the absence of any genomic material originating from Sendai virus,
(2) the presence of fusogenic spikes in a functional orientation, (3) the encapsulation of reporter genes, and (4) high-transfer
activity for plasmids carrying the green fluorescent protein (GFP) gene and double-stranded nucleotides into different
mammalian cells. Transfer rates were up to 10-fold higher than those obtained with different cationic lipids. Gene delivery
by means of our lipid-enriched Sendai virosomes extends the known gene transfer strategies, including those based on
Sendai virus previously published. © 2000 Academic PressINTRODUCTION
The development of methods for the efficient introduc-
tion of foreign genes into living cells aims to provide
tools to elucidate intracellular processes at the molecu-
lar level. In addition, the development of suitable delivery
vectors for in vivo gene transfer is essential for the
clinical application of therapeutic genes. The majority of
the current protocols for gene transfer have involved
nonviral as well as viral methods. Among the former,
liposome-mediated gene transfer has often been used
for DNA delivery into living cells (Felgner et al., 1987;
Ostro and Cullis, 1989; Zenke et al., 1990; Thierry et al.,
1997; for review, see Ledley, 1995). Generally there are
two types of liposome-mediated methods. Electrostatic
transfer includes the formation of ill-defined complexes
between cationic lipids and the negatively charged DNA.
This system allows efficient transfection in vitro, but
gene transfer in vivo is often connected with serious
disadvantages such as cytotoxicity caused by the use of
cationic lipids, which are incompatible with the biologi-
cal environment (Behr et al., 1989; for review, see Gao
and Huang, 1995). In the internal method, on the other
hand, macromolecules are encapsulated into closed1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (4930) 2093-6171. E-mail: msc@mail.vetmed.fu-berlin.de.
391lipid bilayer vesicles prior to transfer (Szoka and Papah-
adjopoulos, 1980; Ostro and Cullis,1989; Reszka et al.,
1995). Although such liposomes may be more stable in
vivo, they have been less efficient than cationic lipids
and were often found to be subject to lysosomal degra-
dation (Bertling et al., 1991; Legendre and Szoka, 1992).
Additionally, a number of viral gene transfer methods
have been developed. Viral vectors make use of the
infection machinery of their complete parent viruses (in-
cluding the viral genome) to transfer DNA into living
cells. This strategy has been employed in the design of
pseudotype retrovirus vectors (Hopkins, 1993), adenovi-
rus-associated vectors (Yang et al., 1994), and lentivirus
vectors (Miyoshi et al., 1999). More recently, a baculovi-
rus vector has been found that appears to hold promise
for transducing mammalian cells (Condreay et al., 1999).
Viral transfection has a higher transformation efficiency
and exhibits stable transduction of nondividing cells.
Because of their small size, however, viral vectors have a
limited capacity for the DNA to be transferred. In addi-
tion, with these vectors safety hazards are not com-
pletely excluded because of the oncogenic potential of
some viruses employed. The risk of random insertion of
genetic elements of the parent virus, possible expres-
sion of undesirable viral genes, and alterations of the
host genome structure cannot be fully avoided.To improve viral delivery systems, we have focused
our efforts on the development of reconstituted Sendai
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392 PONIMASKIN ET AL.viral envelopes, which can be regarded as hybrid vehi-
cles since they are based on both viral and nonviral
strategies. Sendai virus, a member of the Paramyxovirus
family, contains two virus-encoded glycoproteins: the fu-
sion (F) protein and the hemagglutinin-neuraminidase
(HN) protein in its envelope, which are both essential for
initiating infection of the host cell. While HN provides
viral binding to host cell receptors consisting of sialogly-
coproteins or sialolipids, F protein interacts with the lipid
bilayer of the host cell membrane to induce cell fusion
(Galinski and Wechsler, 1991) at neutral pH. In Sendai
virosomal gene transfer this latter property is exploited,
because it introduces DNA directly into the cytoplasm,
thereby avoiding endocytotic pathways and lysosomal
degradation. Several investigators have previously incor-
porated DNA or proteins into Sendai virus envelopes
(Gitman and Loyter, 1984; Gitman et al.,1985) or into the
fusion products of Sendai virus with red blood cell
ghosts (Sugawa et al., 1985) for transfer into target cells.
To date, none of these early methods has developed into
a routine application in gene therapy.
A related but more recent delivery system is based on
viral envelope-modified liposomes, so-called Sendai vi-
rus-liposomes (Kaneda et al., 1987), in which varieties of
macromolecules have been transferred from a mixture of
anionic liposomes and UV-inactivated complete Sendai
virus (Saeki et al., 1997). While apparently working in
vivo, transgene expression mediated by such nondefined
Sendai-liposomes in cultured cells is low (Reszka and
Schmidt, unpublished observations). In addition, such
Sendai-liposomes contain complete viral genomes,
which are transfected into the cells along with the re-
porter gene. This does not seem desirable, especially
during in vivo application, during which the viral genes
could potentially produce unexpected side effects. Gene
delivery based on Sendai virus was also described by
Ramani et al. (1998), who used reconstituted Sendai viral
envelopes containing only F protein. However, their ap-
plication is restricted exclusively to human parenchymal
cells (hepatocytes), which carry the asialoglycoprotein
receptor, to which F protein can bind, and no other
tissues can be targeted.
Here we describe a novel way of producing transfer
vehicles by which polylysine-condensed DNA is effi-
ciently and reproducibly entrapped into Sendai viral en-
velopes during reconstitution of both F and HN protein in
the presence of empirically defined exogenous lipid mix-
tures. This method yields virosomes of a practical size
(capacity) and with high fusogenic activity. The proce-
dure is simple and highly reproducible. When compared
to conventional cationic liposomal vectors, the viro-
somes described here are quite efficient and may well
be advantageous for gene transfer in particular cell types
as for instance endothelial cells.RESULTS
Preparation and characterization of reconstituted
Sendai virosomes
Largely following the classical procedure introduced
by Loyter and coworkers (Gitman and Loyter, 1984; Git-
man et al., 1985), we initially prepared Sendai virosomes
from viral extracts that contained spike proteins and
endogenous viral lipids. SDS–PAGE under reducing con-
ditions of such reconstituted envelopes revealed the
polypeptide pattern after Coomassie blue staining, as
shown in Fig. 1A. Unlike the parent Sendai virus, viro-
somes contain only two prominent bands corresponding
to F and HN protein. To examine the protein identity of
virosomes as well as Sendai virus, proteins were ana-
lyzed by immunoblotting with the use of established
monoclonal antibodies against the individual proteins (a
kind gift from W. J. Neubert, MPI, Munich). The results in
Fig. 1B confirm that the two protein bands from viro-
somes truly represent glycoproteins HN and F, and the
absence of spike proteins in the sediments after enve-
lope extraction demonstrated the efficiency of spike-
solubilization with 1% Triton X-100 (results not shown).
Although the extracted viral glycoproteins remain in the
supernatant after centrifugation, the viral M, NP, P, and L
proteins are all found in the sediment. Since NP, P, and L
proteins are known to be associated with the viral RNA-
genome, no genetic information should be present in the
supernatant extract used for reconstitution (see below).
Electron microscopy after negative staining of recon-
stituted envelopes revealed the presence of different
particle populations (Fig. 2A, upper panel). Only a few of
the analyzed particles showed spherical shape with
sizes varying between 40 and 60 nm (Fig. 2A, lower
panel) and external spikes protruding from their mem-
branes. However, most of the protein spikes did not
appear to be incorporated into the envelopes; instead,
they tended to assemble into bulky (50–100 nm) protein-
aggregates (arrows in Fig. 2A). Judging from previous
reports it seems possible that the hydrophobic parts of F
and HN are associated to form the core of an oligomere
with the hydrophilic heads oriented outward (Shimizu et
al., 1974; Hsu et al., 1981).
To examine whether the addition of exogenous lipids
can augment particle size and/or form of the virosomes,
we prepared a series of lipid mixtures for reconstitution
(Table 1) which contained cholesterol (Chol), sphingomy-
elin (SM), phosphatidylcholine (PC), and phosphati-
dylethanolamine (PE) in varying relative amounts. As
apparent from Table 1 the molar ratios between Chol and
SM (1:1) and between PC and PE (2:1) were kept con-
stant, whereas the total content of Chol and SM was
continually increased from 10 to 100%. All lipid mixtures
were hydrated and added to viral extracts before recon-
stitution was initiated. Quantitative electron microscopy
of the resulting virosomes revealed that the use of ex-
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morphology of the reconstituted envelopes (Fig. 2B). Par-
ticle size increased with rising contents of Chol and SM,
reaching a maximum when these two equimolar lipid
species represented 70% of total lipid. Reconstitution
with Chol:SM:PC:PE in a molar ratio of 3.5:3.5:2:1 (sam-
ple 9, Table 1) resulted in spherical vesicles which re-
semble intact Sendai virus particles in their size and
especially by the appearance of a densely and evenly
packed fringe of spikes on their surface (Fig. 2B, upper
panel). The absence of negative stain in the vesicles also
indicates that optimized virosomes are intact and not
leaky. The presence of correctly oriented F and HN
glycoproteins in the membrane is apparent from immu-
nogold labeling of reconstituted virosomes with poly-
clonal antibodies against Sendai virus following electron
microscopy (Fig. 2C).
Similar results were also obtained after labeling with
monoclonal antibody directed against either F or HN
protein (not shown). About 50% of the virosomes pre-
pared with the above-mentioned optimized lipid compo-
sition were about 100 nm in diameter (Fig. 2B, lower
panel). PAGE analysis resulted in the same protein pat-
tern as shown in Fig. 1A for virosomes prepared just from
endogenous viral lipids. The complete absence of a
functional RNA-genome in the lipid-enriched virosomes
depicted in Fig. 2B was confirmed by infectivity assays
which failed to yield any virus even after four passages
through embryonated eggs (not shown). Both HN and F
FIG. 1. Electrophoretic analysis of reconstituted Sendai virus envel
endai virus (SV) particles and of Sendai virus envelopes (virosomes
hown on the left. (B) For the detection of F and HN protein Sendai vir
onoclonal antibodies directed against HN or F protein. (Monoclonalof the Sendai virus envelope are normally required to
induce either virus-cell fusion or hemolysis of red bloodcells. Our data compiled in Table 1 show that reconsti-
tuted Sendai virosomes are able to hemolyze human
erythrocytes with different yields depending on the re-
constitution protocol. Hemolytic activity was very low
when virosomes were prepared without exogenous lip-
ids; however, the addition of exogenous lipids during
reconstitution markedly enhanced hemolytic activity,
both in rate (not shown) and extent. This increased he-
molytic potential was particularly pronounced with viro-
somes containing Chol:SM:PC:PE in a molar ratio of
3.5:3.5:2:1 (sample 9, Table 1).
Since hemolysis has been treated as a debatable
marker for fusogenic potential in the literature, we char-
acterized the functional features of virosomes in more
detail and chose to measure dequenching kinetics of
human erythrocyte ghosts (HEG) with different virosome
preparations or intact Sendai virions labeled with the
lipidic fluorophore R18. The data in Fig. 3 show that
virosomes prepared without any addition of exogenous
lipids (designated virosomes without lipids) induce only
a slow increase of R18 fluorescence reaching only about
one-fifth of the extent measured for native Sendai virions
(designated SV). However, the presence of exogenous
lipids (Chol:SM:PC:PE 5 3.5:3.5:2:1) during virosome
preparation resulted in a significant increase of fluores-
cence dequenching (FDQ; designated virosomes with
lipids), almost approaching the levels obtained with na-
tive Sendai virus. Since FDQ is widely accepted as a
measure for membrane fusion, it appears from the re-
irosomes). (A) Coomassie-stained gel following SDS–PAGE of intact
stituted from endogenous viral lipids. Molecular weight markers are
reconstituted Sendai virosomes were immunoblotted with the use of
ies were kindly provided by Wolfgang Neubert, MPI, Martinsried.)opes (v
) reconsults in Fig. 3 that the fusogenic activity of virosomes
reconstituted with exogenous lipids in the above-men-
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394 PONIMASKIN ET AL.tioned composition is very similar to that expressed by
native virions. Optimized virosomes with their spikes
blocked by heat denaturation (designated heated viro-
somes) or by antibodies directed against Sendai enve-
lopes or particular spike proteins fail to induce fusion
(data not shown). Such control experiments indicate that
virosomal fusion induction is indeed mediated by the
viral glycoprotein spikes protruding from the virosomal
surface (compare Figs. 2B and 2C).
Encapsulation of DNA into virosomes
To examine the transfection potential of virosomes we
added a plasmid encoding for green fluorescence pro-
tein (pCX-GFP) during reconstitution in the presence of
FIG. 2. Electron microscopy and size analysis of Sendai virosomes.
absence of exogenous lipids (as in Fig. 1). Arrows show aggregated spik
Virosomes reconstituted in the presence of the optimized mixture of
protruding from the envelopes of reconstituted virosomes. Lower panel
of the same type of virosomes incubated with immune serum directed
gold conjugates as described under Materials and Methods. The de
labeling. All cases shown represent the results from one of at least thexogenous lipids. Since unsupported encapsulation of
DNA into virosomes (or liposomes) often results in poor
e
sentrapment because of the large size and negative
charge of the uncondensed DNA (Sternberg et al., 1994),
we added a condensation step prior to reconstitution.
Plasmid DNA and poly-L-lysine (PLL) in a weight ratio
:1.5 in deionized water were rapidly mixed before re-
onstitution. Incorporation of DNA/polylysine-complexes
nto virosomes was eventually assayed by visualizing
Nase-resistant DNA recovered from the reconstitution
roducts after their treatment with SDS. Figure 4 shows
hat only virosomes prepared with the optimized lipid
ixture (compare Table 1) effectively trap PLL-con-
ensed DNA. More importantly, only when pCX-GFP was
LL treated prior to reconstitution does it become DNase
resistant. This indicates that the plasmid is probably
per panel: Negative staining of Sendai virosomes reconstituted in the
er panel: Size distribution of 200 analyzed virosomes. (B) Upper panel:
nous lipids (compare sample 9 in Table 1). Arrows mark the spikes
istribution of 200 analyzed virosomes. (C) Immunoelectron microscopy
t Sendai virus. Bound antibodies were detected using Protein-A 15-nm
gold marker on the virosomes is much higher that the background
ependent experiments which yielded similar distribution patterns.(A) Up
es. Low
exoge
: Size d
againsntrapped into the virosomes rather than sticking to their
urface (Fig. 4, lanes 5 and 6). When virosomes are
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395RECONSTITUTED SENDAI VIROSOMES IN GENE TRANSFERproduced without the addition of exogenous lipids, poly-
lysine-condensed DNA was also found to be associated
with the products (Fig. 4, lane 4). This DNA, however,
was completely digested after treatment of such viro-
somes with DNase I (Fig. 4, lane 3), suggesting that the
plasmid was externally adsorbed rather than encapsu-
lated into virosomes. Condensing DNA with polylysine
appears essential for effective encapsulation, since the
use of uncondensed DNA during reconstitution with op-
timized exogenous lipids resulted mainly in empty viro-
somes (Fig. 4, lanes 1 and 2). The nature of fast-migrat-
ing material, as seen in Fig. 4, is unknown at present;
FIG. 2—Continued
TABLE 1
Effect of Exogenous Lipids Added during Reconstitution
of Sendai Virosomes on Hemolytic Activity
Sample
CHOL
(mol%)
SM
(mol%)
PC
(mol%)
PE
(mol%)
Hemolytic
activity (%)a
1 0 0 0 0 5
2 0 0 67 33 6
3 5 5 60 30 8
4 10 10 53 27 11
5 15 15 47 23 12
6 20 20 40 20 13
7 25 25 33 17 15
8 30 30 27 13 19
9 35 35 20 10 27
10 40 40 13 7 17
11 45 45 7 3 14
12 50 50 0 0 12
13 0 0 67 33 0
a Hemolytic activity of intact parent Sendai virions was set as 100%.
ean hemolytic activity was calculated from at least three independent
xperiments, which deviated by 3% maximally.however, it is unlikely that it represents RNA, since these
bands are resistant to RNaseA treatment (results not
shown). Routine analysis by protein assays and densi-
tometry after agarose gel electrophoresis of encapsu-
lated DNA into optimized virosomes revealed a DNA/
protein ratio of 1 to 2 mg of intact plasmid DNA per mg
total protein. No detectable leakage of DNA was ob-
served when virosomes were left at 4°C in PBS or
DMEM for up to 48 h. We also tested for protein compo-
sition, hemolytic activity, and morphology of optimized
virosomes loaded with PLL/DNA and found that all these
parameters were almost identical to those shown for
virosomes without DNA (compare Figs. 1, 2, and 3).
In vitro gene delivery activity of optimized Sendai
virosomes
Coming back to the key question of gene delivery, we
tested the transfection efficiency of virosomes prepared
with exogenous Chol:SM:PC:PE (3.5:3.5:2:1) and with the
PLL-condensed plasmid pCX-GFP and compared it to
that of cationic lipids. Cultured CV.1, F98, and HUVEC
endothelial cells were transfected as described under
Materials and Methods and subjected to fluorescence
microscopy 48 h later. Parallel cultures of the same cells
were transfected with pCX-GFP by use of specific cat-
ionic lipids. Initially we compared the transfection effi-
FIG. 3. Kinetics of fluorescence dequenching (FDQ) of R18-labeled
Sendai virus (SV) and different Sendai virosomes with human erythro-
cyte ghosts (HEG). HEG were incubated with virosomes reconstituted
in the absence (without lipids) or in the presence (with lipids) of the
optimized lipid mixture. Heat-inactivated optimized virosomes were run
as negative control. Sendai virus or virosomes were added to the HEG
suspension in the cuvette and fusion monitoring started immediately
(t 5 0). At t 5 2500 s, Triton X-100 was added for infinite dilution of the
luorophore and this fluorescence intensity was set to 100% FDQ.
ypical time courses of fusion at 37°C are shown. The kinetics were
ormalized as described under Materials and Methods.ciency of different commercially available as well as
self-prepared cationic lipids to select the most potent
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396 PONIMASKIN ET AL.formula for each cell type used. For CV.1 cells lipofectin
was found to yield the highest transfection level. Rat
glioblastoma cell line F98 was most effectively trans-
fected with cationic lipid mix DC30 (Reszka et al., 1995)
and human umbilical vein endothelial cells (HUVECs)
with Lipofectamin. As shown in Fig. 5, virosomal GFP
expression was detected in all of the cell types investi-
gated (right panels). More importantly, the same figure
demonstrates that virosomal transfer was as efficient
(CV.1 cells) as or even better (F98 and HUVECs) than the
transfer induced by the most potent cationic lipids (left
panel). Transfection efficiency normalized to 1 mg of
CX-GFP DNA was 4% for CV.1 and 2% for endothelial
ells when these were transfected with cationic lipids,
nd 7% for CV.1 and 25% for HUVECs after transfection
ith optimized virosomes. When transfection was done
ith virosomes lacking exogenous lipids, with uncon-
ensed plasmid or with naked plasmid DNA treated with
LL, no expression of GFP was detected in any of the
ell types tested (data not shown). When virosomes were
eat-treated or incubated with polyclonal antibodies
gainst Sendai virus prior to transfection, the number of
ells expressing GFP was reduced to values below 5 and
0%, respectively, when compared to the corresponding
ontrol virosomes (data not shown).
To test the influence of the size of the DNA to be
ransferred we encapsulated 20-bp-long double-
tranded oligonucleotides instead of the GFP-plasmid
FIG. 4. DNase I sensitivity of DNA associated with Sendai virosomes.
ifferently prepared virosomes (15 mg of total protein) were lysed with
% SDS and analyzed by electrophoresis on a 1% agarose gel after
reatment with (1) or without (2) DNase I. A molecular weight marker
phage l DNA digested with BstEII) and untreated pCX-GFP DNA (50
g) were run as controls (lanes l Marker and Control). Lanes 1 and 2:
uncondensed DNA, virosomes prepared with exogenous lipids; lanes 3
and 4: polylysine-condensed DNA, without exogenous lipids present
during reconstitution; lanes 5 and 6: polylysine-condensed DNA, with
exogenous lipid present during reconstitution.nd compared the efficiency of delivering double-
tranded nucleotides in vitro using virosomes or cationic
e
tipids. FITC-labeled and poly-L-lysine-treated double-
tranded nucleotides were transfected to cultured HUVE
ells in parallel to cationic transfection and the transfer
onitored by FACS analysis as well as by fluorescence
icroscopy (Fig. 6). Fluorescence-labeled double-
tranded nucleotides were reconstituted with the above-
entioned exogenous lipids and the resulting Sendai
irosomes prepared and characterized as described ear-
ier. Representative data from multiple experiments in
ig. 6 revealed that FITC-labeled double-stranded nucle-
tides delivered by virosomes were detected in most of
he cells, while cationic lipid transfer was successful in
nly a fraction of the endothelial cells. It is noteworthy
hat, in contrast to cationic transfer, transfection with
irosomes yielded high concentrations of double-
tranded nucleotides in the transfected cells and that
ouble-stranded nucleotides were accumulated predom-
nantly in the nuclei (Fig. 6, lower left panel).
DISCUSSION
The present work describes a new rational and quan-
itative approach for the reconstitution of highly fuso-
enic vesicles derived from Sendai virus envelopes for
elivery of a variety of macromolecules (plasmid DNA
nd double-stranded nucleotides) into different mamma-
ian cells. When compared with the pioneering protocols
f Loyter and coworkers (Gitman and Loyter, 1984; Git-
an et al.,1985), the novelty of our method includes the
ddition of particular exogenous lipids during reconsti-
ution and a poly-L-lysine (PLL) condensation step for the
ucleic acid to be transferred. These measures increase
he transfection efficacy of final virosomes for various
easons as, for instance, by protecting the entrapped
aterial from degradation. The advantage over the viro-
omal-transfer system propagated by Kaneda and co-
orkers (Kaneda et al., 1987; Saeki et al., 1997) is that the
irosomes reported here are active in vitro and fully
haracterized. Most importantly, they are devoid of any
iral genomic material, which represents a potential haz-
rd during application in gene therapy. SDS–PAGE anal-
sis and immunoblotting of the virosomes with monoclo-
al antibodies demonstrate that only F and HN proteins
re presented in the virosomal preparation (Fig. 1),
hereas the nucleocapsid- and M proteins are dis-
arded after centrifugation. The complete absence of
iral genomic material in our virosomes has been sub-
tantiated by the most sensitive procedure available:
erial passage through embryonated eggs.
Since morphological characteristics of reconstituted
articles are often helpful in understanding and predict-
ng functional activities, we first examined the fine struc-
ure of reconstituted virosomes. Figure 2A shows that
uch virosomes reconstituted without the addition of
xogenous lipids are significantly smaller (40–60 nm)
han intact Sendai virions and that many of the protein
a397RECONSTITUTED SENDAI VIROSOMES IN GENE TRANSFERFIG. 5. Expression of green fluorescent protein (GFP) in different cell types transfected with Sendai virosomes or by using Lipofectin. Optimized
Sendai virosomes containing 100 ng of polylysine-condensed pCX-GFP DNA were directly inoculated into CV.1 (B), F98 (D), or human umbilical vein
endothelial cells (F) cultured in 35-mm dishes (5 3 105 cells) as described under Materials and Methods. After incubation at 37°C for 1 h (for CV.1
cells) or for 4 h (for F98 and endothelial cells), the virosome suspension was replaced with DMEM/5% FCS. For comparison the cells were each
transfected with 1 mg of reporter plasmid by using Lipofectin for CV.1 (A), DC30 for F98 (C), and Lipofectamin for HUVEC (E). After 48-h incubation
t 37°C, cells were subjected to fluorescence microscopy to visualize the expression of GFP by counting the fluorescent cells.
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398 PONIMASKIN ET AL.spikes are aggregated. It has been previously reported
that the detergent-extractability profile for cellular lipids
depends on the lipid composition of the membranes
(Davies et al., 1984; Banerjee et al., 1995). For example,
Triton X-100 that was used in our study for solubilization
of Sendai virions has only a limited capacity to extract
sphingomyelin and cholesterol (Davies et al., 1984;
Brown and Rose, 1992). Thus, during extraction of the
viral lipid bilayer by TX-100, these lipid species are par-
tially insoluble and therefore lost from the endogenous
lipids present in the reconstitution mix during centrifu-
gation in the form of insoluble vesicles. Electron micro-
scopic inspection of sediments after TX-100 extraction
revealed the existence of such multilamellar vesicles
(not shown); thus, solubilization of Sendai virions with
TX-100 leads to a selective loss of particular lipids. In
addition, some of the viral envelope phospholipids could
be lost by absorption to the BioBeads used to remove
TX-100 from the system. Altogether, it appears that dur-
ing reconstitution some of the viral envelope lipids are
selectively reduced, thereby leading to a suboptimal pro-
tein/lipid ratio for reconstitution, which results in non-
functional glycoprotein aggregates and in reconstituted
FIG. 6. Histograms of the FACS analysis (upper panel) and of fluor
HUVECs) after transfer of FITC-labeled double-stranded nucleotides. (B
ontaining polylysine-treated FITC-labeled double-stranded nucleotides
nd compared with transfection either by naked double-stranded nucle
irosome suspension was replaced with medium and the incubatio
icroscopy (lower panel). Numbers of cells (counts) are plotted agains
nd transfection efficiency calculated (insert in brackets).virosomes of only small size (Fig. 2A). Accordingly, the
hemolysis and R-18 fusion assays (Table 1 and Fig. 3)revealed only low activities for virosomes reconstituted
exclusively from endogenous lipids.
To overcome this problem we added exogenous phos-
phatidylcholine (PC), phosphatidylethanolamine (PE),
sphingomyelin (SM), as well as cholesterol (Chol) in
various proportions during reconstitution. These lipids
were selected because plasma membranes of animal
cells are known to contain PC, PE, and SM in a similar
range of molar ratios. It has also been demonstrated that
the membrane lipid composition influences the confor-
mation of integral membrane proteins (Stamatatos and
Silvius, 1987; Dracheva et al., 1996), which could be an
important factor in membrane fusion. From liposomal
research it is known that a high cholesterol content
makes liposomal membranes rigid, reduces lipid fluidity,
and facilitates membrane fusion (Stamatatos and Silvius,
1987; McIntosh et al., 1989). In addition, envelopes of
RNA viruses such as HIV, NDV, Sendai virus, and VSV
were reported to contain similar amounts of Chol and
phospholipids (Blough and Lawson,1968; Aloia et al.,
1988) and the biological activities of these viruses (e.g.,
fusion) were diminished when the content of Chol was
reduced (Moore et al., 1978; Citovsky et al., 1986). In our
e microscopy (lower panel) of human umbilical vein endothelial cells
ai virosomes prepared with the optimized exogenous lipid mixture and
ransfected into HUVE cells as described under Materials and Methods
(A) or by use of Lipofectamin (C). After incubation for 4 h at 37°C, the
nued for 1 h prior to FACS analysis (upper panel) or fluorescence
scence intensity. About 50,000 cells were analyzed in each experimentescenc
) Send
were t
otides
n contiempirical approach to add exogenous lipids for maximal
hemolysis, fusogenicity in the R-18 assay, and GFP ex-
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399RECONSTITUTED SENDAI VIROSOMES IN GENE TRANSFERpression after transfection, we found the enrichment of
the reconstitution mixture by Chol:SM:PC:PE in a molar
ratio of 3.5:3.5:2:1 to result in highly efficient virosomes
(Figs. 2, 3, and 5, Table 1). As discussed earlier, the
requirement for a high content of SM and Chol in the
exogenous lipid mixture (35% of each) can be explained
best by the selective insolubility (and loss) of these lipids
during the initial Triton X-100 extraction of purified Sendai
virus. Our results also show that both the phospholipid
composition and the cholesterol/phospholipid ratio have
a pronounced effect on morphology and on the functional
properties of reconstituted virosomes.
Another important parameter that has a considerable
influence on transfection yields is the amount of DNA
encapsulated during reconstitution. Electron micro-
scopic studies on DNA containing liposomes by Stern-
berg et al. (1994) had revealed that DNA molecules are
not well condensed, but may exist in an extended con-
formation reaching up to 600 nm in length. These data
can explain our observation that passive encapsulation
of pCX-GFP DNA into optimized virosomes (which are
;80–100 nm in diameter) results only in poor entrapment
(Fig. 4). Cationic polymers such as polylysine, histones,
and protamine are known to complex and condense
DNA from its extended conformation into highly compact
structures of about 60 nm (Gao and Huang, 1996; Vitiello
et al., 1996). Therefore we included a poly-L-lysine (PLL)
NA condensation step to our reconstitution protocol.
LL possesses a high capacity for DNA condensation
nd is biodegradable. Since it also resembles a nuclear
ocalization signal (Dingwall and Laskey, 1991; Gao and
uang, 1996), it might facilitate active nuclear uptake of
he PLL-DNA complex. Preincubation of DNA with PLL
uring reconstitution results in the association of con-
ensed DNA with virosomes. However, only the viro-
omes prepared in the presence of exogenous lipids
designated optimized virosomes) seem to fully encap-
ulate DNA, thereby making it DNase I-resistant.
In contrast, with virosomes formed exclusively from
ndogenous lipids, DNA was completely digestable by
Nase I, indicating that the plasmid DNA remained
argely accessible, perhaps by sticking to the outer viro-
omal membrane (Fig. 4). These results demonstrate that
oth the addition of exogenous lipids as well as the
ondensation of DNA with PLL prior to reconstitution are
equired to produce the highly effective gene delivery
ystem. Despite the special features required to guaran-
ee the reliable and high transfer potential of the prod-
cts, the reconstitution protocol is quite simple and al-
ows the production of optimized virosomes within 2 days
for schematized flow sheet of procedure, see Fig. 7)
rom Sendai virus concentrates. In attempting to avoid
irus production, we are presently testing reconstitution
rotocols that use the recombinant spike proteins HN
nd F from insect cells (Ponimaskin and Schmidt, unpub-
ished data). Despite the recent observation that F pro-
v
eein may be sufficient for virosomal fusion under certain
onditions (Ramani et al., 1998), we plan to maintain the
se of both F and HN glycoproteins in our virosomes
uring future experiments, because there is evidence
hat HN actively participates in virus-cell fusion (Gitman
nd Loyter, 1984; Bousse et al., 1994; Ponimaskin and
chmidt, unpublished data).
As apparent from Fig. 5, incubation of such loaded
irosomes with the different cell types resulted in the
xpression of GFP, demonstrating that virosomes had
used with and released their contents into the monolay-
red cells (Fig. 5). Heat-treated virosomes as well as
irosomes that had been preincubated with polyclonal
ntibodies against Sendai virus are inefficient in terms of
FP expression. This suggests that delivery is a fusion-
ediated process initiated by the viral spikes located on
he outer surface of virosomes. The competence of op-
imized virosomes in the transfection of glioblastoma
ells (F98) may be exploited for gene delivery into tumor
ells also, and our in vivo experiments are supporting
his possibility (Reszka et al., manuscript in preparation).
he difference in transfer efficiency observed between
irosomal and cationic lipid-mediated delivery is most
triking for endothelial cells, which were only weakly
ransfected with the best of all tested cationic lipids,
ipofectamin (Fig. 5). Likewise, FITC-labeled double-
tranded nucleotides were delivered by virosomes to
ndothelial cells with an efficacy of 50%, whereas it was
nly 20% with the best of all cationic lipids tested. These
esults emphasize the potential advantage of our opti-
ized virosomes.
The double-stranded nucleotides used in our ongoing
tudy possess a high affinity for nuclear factor-kB
(NFkB). This factor plays a pivotal role in the transacti-
FIG. 7. Flow-sheet protocol for reconstitution of optimized Sendai
virosomes. This schematic summarizes the procedure for the prepara-
tion of optimized Sendai virosomes loaded with DNA. The resulting
virosomes are highly fusogenic and capable of efficient gene transfer
into different mammalian cells. For details see Materials and Methods
and Results sections.ation of genes for certain cytokines and adhesion mol-
cules (for review, see Cramer and Muller, 1999) and is
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400 PONIMASKIN ET AL.probably involved in the regulation of the expression of
proteins relevant to myocardial infarction (Morishita et
al., 1997). Our preliminary results along these lines dem-
onstrate that transfer of NFkB oligonucleotides as decoy
ouble-stranded nucleotides into endothelial cells by
se of optimized virosomes is a promising method to
pecifically inhibit the activation of NFkB (Gawaz et al.,
998; Gawaz et al., manuscript in preparation).
All these data together encourage us to pursue our
studies. Considering the high levels of GFP expression
and the efficient transfer of double-stranded nucleotides
achieved in vitro, particularly with endothelial cells, as
well as the ease and the high reproducibility of our
reconstitution procedure, we believe that the Sendai vi-
rosomes reported here are well suited for a wider appli-
cation in therapeutic gene and drug delivery. In contrast
to cationic lipids as a delivery system, our highly fuso-
genic virosomes bear the advantageous potential of ex-
ploiting antibodies for tissue-specific targeting.
MATERIALS AND METHODS
Reagents. Fluorophore octadecyl rhodamine B chlo-
ride (R18) was obtained from Molecular Probes. SM-2
BioBeads were purchased from Bio-Rad. Triton X-100
(TX-100) was obtained from Boehringer Mannheim (Ger-
many). Dulbecco’s modified Eagle’s medium (DMEM),
Lipofectin, and Lipofectamin reagents were purchased
from Life Technologies (Eggenstein, Germany). Fetal calf
serum (FCS) and trypsin-EDTA were obtained from Bio-
Whittaker (Belgium). PIPES, poly-L-lysine, and sphingo-
yelin were from Sigma (St. Louis, MO). Protein A 15-nm
old conjugates were purchased from Plano (Germany).
Virus. Sendai virus (Z strain), initially obtained from R.
ott (Justus-Liebig-University, Gieben), was propagated
n chorioallantoic membranes of 11-day-old embryo-
ated chicken eggs. Diluted viral stock (200 ml) contain-
ng 30 hemagglutinating units per 1 mg protein in PIPES-
buffer (5 mM PIPES [pH 7.5], 145 mM NaCl) was used to
infect the eggs, which were then incubated at 37°C for
48 h. The infection process was terminated by placing
the eggs at 4°C overnight. The allantoic fluid was har-
vested and centrifuged at 1500 g for 30 min at 4°C and
the clear supernatant was collected. Virus was sedi-
mented at 25,000 g for 2.5 h at 4°C in a Beckman L7
ultracentrifuge using a Beckman type 19 rotor. The virus
sediment was suspended in a small volume of PIPES-
buffer. The viral yield from 100 eggs was 10–40 mg of
total viral protein. The purified virus was adjusted to a
final protein concentration of 2 mg/ml by adding PIPES-
buffer and 2.5-ml aliquots (5 mg total viral protein) were
stored at 270°C until further use.
Plasmid and double-stranded nucleotides. The plas-
mid pCX-GFP, containing cytomegalovirus promotor-en-
chancer element and b-actin/b-globin promoter linked to
the green fluorescence protein (GFP) gene was obtainedfrom Drs. M. Okabe and J. Miyazaki (Osaka University,
Japan) (Miyazaki et al., 1989). The 20-bp-long phospho-
rothioate double-stranded nucleotides derived from the
second kB site within the human MCP-1 promoter and
labeled with fluorescein isothiocyanate (FITC) at the 59
end (59-FITC-AGA GTG GGA ATT TCC ACT CA-39) were
purchased from MWG (Ebersberg, Germany). The dou-
ble-stranded nucleotides were dissolved in balanced
salt solution (135 mM NaCl, 5.4 mM KCl, 10 mM Tris–HCl
[pH 7.6]) at a concentration of 50 mM. Supercoiled plas-
mid pCX-GFP was isolated from E. coli strain TG1 (Strata-
gen) by QIAGEN-Maxi plasmid purification kit according
to the manufacturer’s protocol.
Preparation of lipids. Lipid mixtures from cholesterol,
sphingomyelin, phosphatidylcholine, and phosphati-
dylethanolamine in various combinations were prepared
by dissolving in 2 ml of chloroform. They were then dried
as a thin film to the walls of glass tubes by evaporation
of the solvent. The dried lipid mixture was hydrated in
600 ml of PIPES-buffer containing 0.5% of Triton X-100 by
intensive rocking immediately before reconstitution.
Preparation of Sendai virosomes loaded with pCX-GFP
or double-stranded nucleotides. A suspension of Sendai
virus in PIPES-buffer (5 mg total protein) was centrifuged
at 80,000 g for 30 min at 4°C in a Beckman ultracentri-
fuge using a SW35 rotor and the viral pellet resuspended
in 300 ml of PIPES-buffer containing 1% of Triton X-100.
After incubation at 4°C for 1 h, the suspension was
centrifuged at 100,000 g for 50 min at 4°C to remove
detergent-insoluble material. While this centrifugation
was in progress, DNA-PLL complexes were prepared by
mixing aliquots of pCx-GFP plasmid DNA (100 mg) or
double-stranded nucleotides (50 mg) with varying
mounts of PLL followed by incubation at 20°C for 10
in. From the previously described suspension in
IPES-buffer with 0.5% TX-100, 600 ml of lipid were then
dded and the incubation continued for an additional 30
in at 20°C. The mixture of PLL-treated DNA (65 mg of
DNA/mg of viral input protein) and lipids (275 nmol/mg of
viral input protein) was added to the clear supernatant
from the previous centrifugation, which contained the
Triton X-100 solubilized fraction (i.e., the spike glycopro-
teins F and HN of Sendai virus). Virosomes were recon-
stituted by stepwise removal of detergent with the use of
SM-2 BioBeads. Briefly, 30 mg of methanol-washed SM-2
BioBeads were added to the above-mentioned suspen-
sion and incubated at 20°C with gentle rocking. After 2 h
an additional 60 mg of SM-2 was added and the incuba-
tion continued for 4 h. Finally, 90 mg of SM-2 BioBeads
was added to the suspension and reconstitution ex-
tended for another 16 h. The virosome suspension was
then carefully aspirated from BioBeads with the use of a
26-gauge needle and centrifuged at 100,000 g at 4°C for
45 min in a TLA-100.2 rotor with the use of a Beckman
TL-100 ultracentrifuge. The virosome sediment was re-
suspended in 3 ml DMEM medium to a final protein
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401RECONSTITUTED SENDAI VIROSOMES IN GENE TRANSFERconcentration of 0.1 to 0.5 mg/ml and stored at 4°C until
further use.
Hemolysis assay. RBCs were drawn from a healthy
hicken into heparin-coated tubes and washed three
imes with PBS. Washed RBCs were resuspended at a
oncentration of 1% (v/v) in PBS. RBCs (1%, 600 ml) were
ixed with 200 ml of Sendai virus or virosomes (1 mg
total protein) and this mixture was left on ice for 30 min,
followed by a 60-min incubation at 37°C. The reaction
was terminated by chilling on ice and the mixture spun at
1000 g for 15 min. Hemoglobin released into the super-
atant was measured at 540 nm in a spectrophotometer.
he amount of hemoglobin released in the presence of
% TX-100 was taken as the reference value for 100%
ysis.
R-18 fusion assay. For labeling Sendai virus or viro-
omes with the lipid probe octadecyl rhodamine B chlo-
ide (R18), samples containing 1 mg protein were mixed
ith 10 nM R18 in ethanol under vortexing. After incuba-
ion for 30 min at room temperature in the dark, the
reparation was centrifuged and the sediment resus-
ended in PIPES-buffer. After washing four times the
abeled samples were kept in PIPES containing 1 mM
ach of CaCl2 and MgCl2. Ghosts were prepared from
human erythrocytes by hypotonic lysis in 5 mM sodium
phosphate in the presence of BSA as previously de-
scribed (Schwoch and Passow, 1973). To initiate the
assay 20 ml of the R18-labeled sample (containing 20 mg
otal protein) was added to a cuvette containing 1.93 ml
f prewarmed PIPES-buffer (37°C) containing 1 mM each
f Ca21 and Mg21, and 50 ml of ghost suspension (50 mg
protein). FDQ of R18 was measured continuously by
using a spectrofluorimeter (SLM Aminco-Bowman, se-
ries 2) with 0.5-s time resolution at excitation and emis-
sion wavelengths of 560 and 595 nm, respectively. A
570-nm cutoff filter was placed in the emission optical
pathway to reduce scattering. To normalize the data, the
percentage FDQ (%FDQ) at any time point was calcu-
lated from the equation: %FDQ 5 100[F(t) 2 F0]/(FT 2 F0),
where F0 and F(t) are fluorescence intensities at time 0
nd at a given time point t, and FT is the fluorescence
intensity in the presence of 0.5% Triton X-100, defined as
the fluorescence at “infinite” dilution of the probe (Morris
et al., 1989).
Electron microscopy. Virosome samples were placed
on formovar/carbon-coated copper grid and then stained
either with 2% uranyl acetate for 2 min or with 2% am-
monium molybdate for 1 min. Grids were dried and
examined by JEM 100CX transmission electron micro-
scope (Jeol, Tokyo, Japan), operating at an accelerating
voltage of 80 kV with a magnification from 15,000 to
100,0003. Results were documented on Agfa-EM film
(Plano, Wetzlar). For quantification 200 to 800 virosomes
were analyzed for each lipid composition and mean
sizes were then determined. For immunoelectron micros-copy a protein A-gold technique was used as previously
described (Slot and Geuze, 1985), with minor modifica-
tions. After absorption of virosomes on a formvar/carbon-
coated nickel grid for 20 min, the specimen was treated
with 50 mM glycine in phosphate-buffered saline (PBS)
and washed twice with PBS containing 0.2% gelatin and
0.5% bovine serum albumin (PBG). The sample was in-
cubated with diluted polyclonal rabbit antibodies di-
rected against Sendai virus or with monoclonal antibod-
ies directed against either F or HN protein (1/100 or
1/1000 in PBG) for 1 h and then washed with PBG, PBS,
and Aqua bidest, followed by incubation with protein
A-gold conjugates (1/100 or 1/200 in PBG) for 1 h. Finally,
the grids were stained either with 2% uranyl acetate or
with 2% ammonium molybdate and examined by trans-
mission electron microscopy as described earlier.
Cell culture and transfection of cultured cells. CV.1 and
F98 cells were maintained as monolayer cultures in
DMEM supplemented with 5% FCS. Primary HUVECs
were harvested by use of collagenase digestion as de-
scribed (Gawaz et al., 1998). Cells were pooled from
hree to six prepared umbilical veins and were grown in
omplete medium composed of M199 (Sigma), 10% FCS,
mM glucose, 100 U/ml penicillin, and 100 mg/l strep-
omycin and used as confluent monolayers after one to
wo passages. All cell types were grown in 35-mm
ishes (5 3 105 cells), washed twice with appropriate
edium without FCS, and transfection was initiated by
dding 300 ml of virosomes (150 mg total protein) in
medium. After 1 h for CV.1 cells or 4 h for F98 and
HUVECs, incubation at 37°C in 5% CO2 virosome sus-
pension was replaced with a complete medium and cells
were further incubated for 48 h. For a comparative as-
sessment of gene transfer, all cell types were transfected
in parallel with 1 mg of pCX-GFP DNA with the use of
ipofectin (Life Techologies) for CV.1 cells, Lipofectamin
Life Technologies) for HUVE cells, and DC30 for F98.
ransfection protocols were as described by the manu-
acturer (Lipofectin, Lipofectamin) or as previously re-
orted (DC30) (Reszka et al., 1995). The total amount of
irosomal DNA applied to the cells in all other experi-
ents is specified with the respective results.
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